2024 Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough Read More » 2024-12-11 2024 Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy Read More » 2024-12-11 2024 Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases Read More » 2024-12-11 2024 Beroni Group’s Ten-year Research Journey, Innovation Leads the Future Read More » 2024-12-04 2024 Beroni Group Has Obtained Four Invention Patents in the Field of Small Nucleic Acid Drugs for the Treatment of Liver Cirrhosis Read More » 2024-12-04 2024 Beroni Group Launched Beilemei No.5 Compound Probiotics Read More » 2024-12-04 2024 Beroni Group Has Made a Breakthrough in the Field of Targeted Small Nucleic Acid Drugs for the Treatment of Liver Cirrhosis Read More » 2024-12-04 2024 New Year Greetings from Mr. Jacky Zhang！ Read More » 2024-02-09 2023 Wish You Happy New Year！ Read More » 2023-12-29 2023 Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau Read More » 2023-11-23 2023 Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum Read More » 2023-09-15 2023 Successful Conclusion to the Conference of FET Read More » 2023-07-31 2023 Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement Read More » 2023-04-06 2023 Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit Read More » 2023-02-08 2022 Wish You Happy New Year！ Read More » 2022-12-30 2022 Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project Read More » 2022-12-30 2022 Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association Read More » 2022-11-11 2022 Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium Read More » 2022-09-05 2022 Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics Read More » 2022-07-11 2022 Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification Read More » 2022-06-01 2022 New Year Greetings from Mr. Jacky Zhang！ Read More » 2022-01-31 2022 The new school building of Beroni Hope School in Garzê is officially open for use Read More » 2022-01-21 2021 Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan Read More » 2021-11-19 2021 Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal Read More » 2021-10-29 2021 Successful Conclusion to Beroni Group’s 2021 Team Building Activity Read More » 2021-10-22 2021 Beroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference Read More » 2021-09-30 2021 Beroni Group Wishing You Happy Mid-Autumn Festival！ Read More » 2021-09-18 2021 Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method) Read More » 2021-09-01 Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO Read More » 2021-09-01 Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment Read More » 2021-05-28 2021 Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit Read More » 2021-04-27 2021 New Year Greetings from Mr. Jacky Zhang！ Read More » 2021-02-09 2021 Wish You Happy New Year！ Read More » 2021-01-01 2020 Major Events of Beroni Group Limited in 2020 Read More » 2020-12-31 2020 Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification Read More » 2020-12-22 2020 Beroni Group Launches a New Probiotics Health Product in China Read More » 2020-11-10 2020 Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020 Read More » 2020-11-10 Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19 Read More » 2020-10-21 2020 Beroni Group Collaborates with Genscript Biotech Corporation Read More » 2020-08-17 Beroni Group to Supply COVID-19 Antibody Test Kit to Japan Read More » 2020-07-14 2020 Representatives of Huarong Securities Co., Ltd Visit Beroni Group Read More » 2020-05-29 2020 Strategic Cooperation between Beroni Group and BG Health Read More » 2020-05-19 2020 Beroni Group and Tianjin University have made a significant discovery in developing a medical solution using nanobody technology for the novel coronavirus Read More » 2020-05-19 2020 Beroni China (product: SARS-CoV-2 IgG/IgM Antibody Detection Kit) is included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries Read More » 2020-05-19 2020 Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit Read More » 2020-04-01 2020 Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19) Read More » 2020-03-13 2020 Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19) Read More » 2020-03-06 2020 Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA Read More » 2020-02-14 2020 Beroni Group looking to up-list to the Nasdaq Read More » 2020-02-05 2020 Successful Conclusion to Beroni China’s 2019-2020 Work Summary Meeting & New Year’s Gala Read More » 2020-01-08 Search Article Search this website Arrange by Year 2017 (10) 2018 (24) 2019 (25) 2020 (17) 2021 (11) 2022 (8) 2023 (6) 2024 (8) What’s New Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases Beroni Group’s Ten-year Research Journey, Innovation Leads the Future Beroni Group Has Obtained Four Invention Patents in the Field of Small Nucleic Acid Drugs for the Treatment of Liver Cirrhosis
2024 Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough Read More » 2024-12-11
2024 Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy Read More » 2024-12-11
2024 Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases Read More » 2024-12-11
2024 Beroni Group Has Obtained Four Invention Patents in the Field of Small Nucleic Acid Drugs for the Treatment of Liver Cirrhosis Read More » 2024-12-04
2024 Beroni Group Has Made a Breakthrough in the Field of Targeted Small Nucleic Acid Drugs for the Treatment of Liver Cirrhosis Read More » 2024-12-04
2023 Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau Read More » 2023-11-23
2023 Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum Read More » 2023-09-15
2023 Beroni and Shenyang University Of Chemical Technology Successfully Signed the Practice Base Agreement Read More » 2023-04-06
2023 Beroni Group Advances Research and Development of its Enhanced COVID-19 Antigen Rapid Test Kit Read More » 2023-02-08
2022 Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project Read More » 2022-12-30
2022 Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association Read More » 2022-11-11
2022 Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium Read More » 2022-09-05
2022 Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics Read More » 2022-07-11
2022 Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification Read More » 2022-06-01
2022 The new school building of Beroni Hope School in Garzê is officially open for use Read More » 2022-01-21
2021 Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan Read More » 2021-11-19
2021 Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal Read More » 2021-10-29
2021 Beroni Group was invited to attend the 6th China BioMed Innovation and Investment Conference Read More » 2021-09-30
2021 Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method) Read More » 2021-09-01
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment Read More » 2021-05-28
2021 Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit Read More » 2021-04-27
2020 Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification Read More » 2020-12-22
2020 Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020 Read More » 2020-11-10
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19 Read More » 2020-10-21
2020 Beroni Group and Tianjin University have made a significant discovery in developing a medical solution using nanobody technology for the novel coronavirus Read More » 2020-05-19
2020 Beroni China (product: SARS-CoV-2 IgG/IgM Antibody Detection Kit) is included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries Read More » 2020-05-19
2020 Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit Read More » 2020-04-01
2020 Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19) Read More » 2020-03-13
2020 Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19) Read More » 2020-03-06
2020 Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA Read More » 2020-02-14
2020 Successful Conclusion to Beroni China’s 2019-2020 Work Summary Meeting & New Year’s Gala Read More » 2020-01-08
